Finance

Beta
Lists
2070:TADAWUL
Saudi Pht Ind nd Mdl Apl Crp SPM ADW SJS
SAR 28.32
-0.84%
(-0.24) 1D
Jun 10, 3:16:34 PM GMT+3  ·   SAR
All symbols
SymbolPriceChange% Change
Generating top insights for 2070...
Open
SAR 28.40
High
SAR 28.40
Low
SAR 28.12
Mkt. cap
3.40B
Avg. vol.
411.34K
Volume
143.15K
Dividend
1.24%
Quarterly dividend
SAR 0.09
Ex-dividend date
Jun 10, 2026
P/E ratio
18.92
52-wk high
SAR 33.12
52-wk low
SAR 21.76
EPS
SAR 1.50
Shares outstanding
119.28M
Open
SAR 28.40
High
SAR 28.40
Low
SAR 28.12
Mkt. cap
3.40B
Avg. vol.
411.34K
Volume
143.15K
Dividend
1.24%
Quarterly dividend
SAR 0.09
Ex-dividend date
Jun 10, 2026
P/E ratio
18.92
52-wk high
SAR 33.12
52-wk low
SAR 21.76
EPS
SAR 1.50
Shares outstanding
119.28M
News stories
From sources across the web
About Saudi Pht Ind nd Mdl Apl Crp SPM ADW SJS
CEO-
Employees-
FoundedJan 20, 1986
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in SAR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SAR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
400.76M
415.30M
405.80M
423.83M
Cost of goods sold
206.68M
212.39M
211.04M
187.72M
Cost of revenue
206.68M
212.39M
211.04M
187.72M
Research and development expenses
15.07M
13.76M
18.78M
11.12M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
126.71M
132.63M
123.88M
122.08M
Operating expense
133.63M
129.53M
194.27M
145.62M
Total operating expenses
340.31M
341.92M
405.31M
333.34M
Operating income
60.45M
73.38M
498.00K
90.49M
Other non operating income
-
-
-
-
EBT including unusual items
48.07M
50.12M
36.97M
77.81M
EBT excluding unusual items
49.54M
57.11M
-6.74M
78.34M
Income tax expense
12.02M
6.54M
-5.14M
9.66M
Effective tax rate
25.01%
13.04%
-13.92%
12.42%
Other operating expenses
-2.72M
-16.86M
30.30M
-6.90M
Net income
32.63M
42.14M
38.77M
65.07M
Net profit margin
8.14%
10.15%
9.55%
15.35%
Earnings per share
-
-
-
-
Interest and investment income
3.01M
2.60M
4.88M
2.74M
Interest expense
-24.67M
-23.23M
-16.55M
-19.69M
Net interest expenses
-21.67M
-20.63M
-11.68M
-16.95M
Depreciation and amortization charges
-
-
-
-
EBITDA
86.15M
103.80M
20.20M
112.91M
Gain or loss from assets sale
-427.00K
-10.92M
716.00K
276.00K
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more